Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU

NCT04799600 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.

NCT NCT04799600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04799600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU
Lead sponsor
Ankara City Hospital Bilkent
Phase
Observational
Overall status
Completed
Start date
September 1, 2020
Completion date
July 1, 2021
Enrollment
158 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal failure, covid19